Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04792099 · ClinicalTrials.gov registry record · NA
CPAP Or Nasal Cannula Oxygen for Preterm Infants: A Randomized Controlled Trial
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT04792099 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 38 participants.
The verdict
NCT04792099, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if in preterm infants \< 34 weeks' gestation at birth receiving respiratory support with continuous positive airway pressure (CPAP) or nasal cannula (NC), CPAP compared with NC will decrease the number of episodes with oxygen saturations less than 85% of ≥10 seconds in a 24-hour randomized controlled trial. This will be a randomized controlled trial with a 1:1 parallel allocation of infants to CPAP or NC oxygen using stratified permuted block design.
Interventions
- PROCEDURE Continuous positive airway pressure
- PROCEDURE Nasal Cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2023-03-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04792099
The ClinicalTrials.gov registry entry for NCT04792099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous positive airway pressure is the first listed.
NCT04792099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04792099 about?
NCT04792099 is a clinical study titled "CPAP Or Nasal Cannula Oxygen for Preterm Infants: A Randomized Controlled Trial". The purpose of this study is to determine if in preterm infants \< 34 weeks' gestation at birth receiving respiratory support with continuous positive airway pressure (CPAP) or nasal cannula (NC), CPAP compared with NC will decrease the number of episodes with oxygen saturations less than 85% of ≥10...
What is the current status of trial NCT04792099?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2021-08-16. Estimated completion is 2023-03-29.
What interventions are being tested in trial NCT04792099?
The interventions under investigation include: Continuous positive airway pressure (PROCEDURE), Nasal Cannula (PROCEDURE).
Who is sponsoring clinical trial NCT04792099?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.